Sentinel Node Biopsy Market Research Report- Forecast to 2027

Sentinel Node Biopsy Market Research By-Product (Breast Localization Wire, Tissue Marker, Gamma Probe, Drainage Catheters), Indication (Breast Cancer, Melanoma, Colon Cancer, Esophageal Cancer), End-User (Hospitals & Clinics, Diagnostic Centers) - Global Forecast Till 2027

ID: MRFR/MED/4133-HCR | February, 2021 | Region : Global

Market Synopsis


A sentinel lymph node biopsy is a medical procedure, which involves identification, removal, and examination of the lymph node to verify the presence of cancer cells. Lymph nodes are a part of the lymphatic system which is found throughout the body and is connected to the lymph vessels.  Breast cancer, melanoma, colon cancer, esophageal cancer, head and neck cancer, non-small cell lung cancer, stomach cancer, thyroid cancer are various indications for biopsy. The procedure helps the healthcare provider to determine the stage of cancer, its metastasis in order to plan a line of treatment for the patient.


Rising prevalence of various types of cancer such as breast cancer, melanoma, colon cancer and growing emphasis on women healthcare are the major drivers for the growth of the market. Additionally, increasing number of health problems women further fuel the market growth. Demand for diagnosis and treatment of breast cancer and the technologically advanced medical device is found to be increasing across the globe.  Furthermore, increasing healthcare expenditure and overall growth of healthcare industry also influence the market growth. Extensive research in the field of reproductive health and diseases also boost the market. Increasing demand for new products and accessories with advent of technology in the healthcare industry also fuels the growth of the market across the globe. However, various factors restrained the market growth such as complications associated with the biopsy and unawareness among women.


The global sentinel node biopsy market is expected to grow at a CAGR of 5.1% during the forecast period.


Key Players in the Global Sentinel Node Biopsy Market 


Some of the key players in this market are Devicor Medical Products, Inc., part of Leica Biosystems. (Germany), C. R. Bard, Inc. (U.S.), INTRAMEDICAL IMAGING LLC (U.S.), Hilfe Engineering Corporation (India), Surgic Eye (Germany), KUB Technologies, Inc. (U.S.), Navidea Biopharmaceuticals, Inc.(U.S.) and others.


Sentinel Node Biopsy Market Segments


The global sentinel node biopsy market is segmented on the basic product, indication, and end user.


On the basis of product, the sentinel node biopsy market is segmented into breast localization wire, tissue marker, gamma probe, drainage catheter, and others


On the basis of indication, the sentinel node biopsy market is segmented into breast cancer, melanoma, colon cancer, esophageal cancer, and others.


On the basis of the end user, the sentinel node biopsy market is segmented into hospitals & clinics, diagnostic centers, and others.


Intended Audience



  • Medical Device Manufacturers

  • Medical Device Suppliers

  • Medical Research Laboratories

  • Healthcare IT Companies

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Regional Analysis of the Global Sentinel node biopsy Market             


America captures the first position for sentinel node biopsy market is driven by increasing number of women suffering from breast disorders and rising prevalence of breast cancer in the U.S. and Canada. Furthermore, the market is also driven by the availability of technologically advanced medical devices and quality care in healthcare institutes. In Americas, North America is the major market due to increasing number of market players offering biopsy devices and instruments. As per the American Cancer Society, in 2015, there were 231,840 new cases of breast cancer, and till March 2017, there were 3.1 million women with a history of breast cancer in the U.S. As per the National Cancer Institute, 2016, in the U.S. around 1,685,210 new cases of cancer were diagnosed and in 2014, around 15,780 children and adolescents ages 0 to 19 were diagnosed with cancer and 1,960 died of the disease.


In Europe, sentinel node biopsy market shows better growth opportunities governed by the ongoing research and development activities in the field of oncology. In Europe, there is an increasing demand for medical devices and availability of funds for research and development activities in the reproductive health. Germany acquires the first position the European market owing to an increasing demand for cancer diagnosis. France and U.K secure second and third position are respectively owing to the availability of tertiary care facilities in these countries and rising healthcare expenditure.


The Asia Pacific is the fastest growing region for the sentinel node biopsy market whose growth is determined by the presence of highly skilled workforce and increasing demand for biopsy procedures in hospitals and specialty care centers. India and China exhibit enormous growth opportunities owing to ever increasing the prevalence of chronic diseases, increase in a number of women suffering for reproductive disorders, and increasing expenditure on surgical procedures industry by key players in developing economies throughout the Asia Pacific.


In the Middle East, Saudi Arabia and the United Arab Emirates are the major countries holding the largest share in the market. Increase in the number of specialty care services and rising demand for diagnosis of various types of cancer are the key drivers of the sentinel node biopsy market. Africa exhibits slow growth owing to limited penetration of technology in this region and unawareness about sentinel node biopsy.


FIGURE 1: Global Sentinel node biopsy Market by Region, 2016 (%)


 Sentinel node biopsy


Source: World Health Organization, Centers for Disease Control and Prevention, U.S. National Library of Medicine, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Research Methodology The report for Global Sentinel Node Biopsy Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.


 Sentinel node biopsy 1


Source: World Health Organization, Centers for Disease Control and Prevention, U.S. National Library of Medicine, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Sentinel Node Biopsy Market, By Product

6.1 Introduction

6.2 Breast Localization Wire

6.2.1 Market Estimates & Forecast, 2020 – 2027

6.3 Tissue Marker

6.3.1 Market Estimates & Forecast, 2020 – 2027

6.4 Gamma Probe

6.4.1 Market Estimates & Forecast, 2020 – 2027

6.5 Drainage Catheters

6.5.1 Market Estimates & Forecast, 2020 – 2027

6.6 Others

6.6.1 Market Estimates & Forecast, 2020 – 2027

7. Global Sentinel Node Biopsy Market, By Indication

7.1 Introduction

7.2 Breast Cancer

7.2.1 Market Estimates & Forecast, 2020 – 2027

7.3 Melanoma

7.3.1 Market Estimates & Forecast, 2020 – 2027

7.4 Colon Cancer

7.4.1 Market Estimates & Forecast, 2020 – 2027

7.5 Esophageal Cancer

7.5.1 Market Estimates & Forecast, 2020 – 2027

8. Global Sentinel Node Biopsy Market, By End User

8.1 Introduction

8.2 Hospitals & Clinics

8.2.1 Market Estimates & Forecast, 2020 – 2027

8.3 Diagnostic Centers

8.3.1 Market Estimates & Forecast, 2020 – 2027

8.4 Others

8.4.1 Market Estimates & Forecast, 2020 – 2027

9. Global Sentinel Node Biopsy Market, By Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest Of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic Of Korea

9.4.6 Rest Of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest Of The Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Devicor Medical Products, Inc., Part Of Leica Biosystems.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.2.4 Key Developments

11.2 C. R. Bard, Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.3 INTRAMEDICAL IMAGING

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.4 Hilfe Engineering Corporation

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.5 Surgic Eye

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial Overview

11.5.4 Key Developments

11.6 KUB Technologies, Inc.

11.6.1 Overview

11.6.2 Product Overview

11.6.3 Financials

11.6.4 Key Developments

11.7 Navidea Biopharmaceuticals, Inc.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.8 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Medical Device Industry

13 Appendix

LIST OF TABLES

Table 1 Sentinel Node Biopsy Industry Synopsis, 2020 – 2027

Table 2 Global Sentinel Node Biopsy Market Estimates And Forecast, 2020 – 2027, (USD Million)

Table 3 Global Sentinel Node Biopsy Market By Region, 2020 – 2027, (USD Million)

Table 4 Global Sentinel Node Biopsy Market By Products, 2020 – 2027, (USD Million)

Table 5 Global Sentinel Node Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 7 Global Sentinel Node Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 8 North America Sentinel Node Biopsy Market By Products, 2020 – 2027, (USD Million)

Table 9 North America Sentinel Node Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 11 North America Sentinel Node Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 12 US Sentinel Node Biopsy Market By Products, 2020 – 2027, (USD Million)

Table 13 US Sentinel Node Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 15 US Sentinel Node Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 16 Canada Sentinel Node Biopsy Market By Products, 2020 – 2027, (USD Million)

Table 17 Canada Sentinel Node Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 19 Canada Sentinel Node Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 20 South America Sentinel Node Biopsy Market By Products, 2020 – 2027, (USD Million)

Table 21 South America Sentinel Node Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 23 South America Sentinel Node Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 24 Europe Sentinel Node Biopsy Market By Products, 2020 – 2027, (USD Million)

Table 25 Europe Sentinel Node Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 27 Europe Sentinel Node Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 28 Western Europe Sentinel Node Biopsy Market By Products, 2020 – 2027, (USD Million)

Table 29 Western Europe Sentinel Node Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 31 Western Europe Sentinel Node Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 32 Eastern Europe Sentinel Node Biopsy Market By Products, 2020 – 2027, (USD Million)

Table 33 Eastern Europe Sentinel Node Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 35 Eastern Europe Sentinel Node Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 36 Asia Pacific Sentinel Node Biopsy Market By Products, 2020 – 2027, (USD Million)

Table 37 Asia Pacific Sentinel Node Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 39 Asia Pacific Sentinel Node Biopsy Market By End Users, 2020 – 2027, (USD Million)

Table 40 Middle East & Africa Sentinel Node Biopsy Market By Products, 2020 – 2027, (USD Million)

Table 41 Middle East & Africa Sentinel Node Biopsy Market By Indication, 2020 – 2027, (USD Million)

Table 43 Middle East & Africa Sentinel Node Biopsy Market By End Users, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Sentinel Node Biopsy Market

Figure 3 Segmentation Market Dynamics For Sentinel Node Biopsy Market

Figure 4 Global Sentinel Node Biopsy Market Share, By Product, 2020

Figure 5 Global Sentinel Node Biopsy Market Share, By Indication, 2020

Figure 6 Global Sentinel Node Biopsy Market Share, By End Users, 2020

Figure 7 Global Sentinel Node Biopsy Market Share, By Region, 2020

Figure 8 North America Sentinel Node Biopsy Market Share, By Country, 2020

Figure 9 Europe Sentinel Node Biopsy Market Share, By Country, 2020

Figure 10 Asia Pacific Sentinel Node Biopsy Market Share, By Country, 2020

Figure 11 Middle East & Africa Sentinel Node Biopsy Market Share, By Country, 2020

Figure 12 Global Sentinel Node Biopsy Market: Company Share Analysis, 2020 (%)

Figure 13 Devicor Medical Products, Inc., Part Of Leica Biosystems.: Key Financials

Figure 14 Devicor Medical Products, Inc., Part Of Leica Biosystems.: Segmental Revenue

Figure 16 Devicor Medical Products, Inc., Part Of Leica Biosystems.: Geographical Revenue

Figure 17 Navidea Biopharmaceuticals, Inc.: Key Financials

Figure 18 CNavidea Biopharmaceuticals, Inc.: Segmental Revenue

Figure 19 Navidea Biopharmaceuticals, Inc.: Geographical Revenue

Figure 20 INTRAMEDICAL IMAGING: Key Financials

Figure 21 INTRAMEDICAL IMAGING: Segmental Revenue

Figure 22 INTRAMEDICAL IMAGING: Geographical Revenue

Figure 23 Hilfe Engineering Corporation: Key Financials

Figure 24 Hilfe Engineering Corporation: Segmental Revenue

Figure 25 Hilfe Engineering Corporation: Geographical Revenue

Figure 26 Surgic Eye: Key Financials

Figure 27 Surgic Eye: Segmental Revenue

Figure 28 Surgic Eye: Geographical Revenue

Figure 29 C. R. Bard, Inc.: Key Financials

Figure 30 C. R. Bard, Inc.: Segmental Revenue

Figure 31 C. R. Bard, Inc.: Geographical Revenue

Figure 32 KUB Technologies, Inc.: Key Financials

Figure 33 KUB Technologies, Inc.: Segmental Revenue

Figure 34 KUB Technologies, Inc.: Geographical Revenue